Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Rheumatology (Oxford, England)|July 5, 2022
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVEPhilip J Mease, Akihiko Asahina, Dafna D Gladman, et al.
The Journal of Rheumatology|December 1, 2025
Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With GuselkumabWilliam Tillett, Laura C Coates, Marijn Vis, et al.
Rheumatology (Oxford, England)|March 15, 2024
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panelLaura C Coates, Marwan Bukhari, Antoni Chan, et al.
The Journal of Rheumatology|August 3, 2017
A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic ArthritisWilliam Tillett, Emma Dures, Sarah Hewlett, et al.
Rheumatology (Oxford, England)|October 19, 2019
Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)Ana-Maria Orbai, Alexis Ogdie, Laure Gossec, et al.
RMD Open|March 31, 2023
Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsAPascal Richette, Marijn Vis, Sarah Ohrndorf, et al.
Clinical and Experimental Rheumatology|July 5, 2023
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 studyPhilip Mease, Arathi Setty, Kim Papp, et al.
The Lancet. Rheumatology|January 30, 2024
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 studyLaura C Coates, William Tillett, Maria-Antonietta D'Agostino, et al.
The Journal of Rheumatology|March 3, 2019
Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort StudyAnna S Antony, Andrew Allard, Adwaye Rambojun, et al.
Rheumatology (Oxford, England)|August 16, 2014
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre studyWilliam Tillett, Gavin Shaddick, Ayman Askari, et al.
Pageof 13